Finally scrubbing off the stain Theranos cast on the diagnostics industry, new technologies are popping up with groundbreaking use cases that can transform the way we diagnose disease. A drop of blood can now actually unveil a comprehensive picture of personalized health, it just took us a little longer to get here. These innovations are shifting the industry even further from reactive treatment to predictive, personalized healthcare. From discovering a nascent autoimmune condition before symptoms fully manifest to providing a remote community access to advanced diagnostics through a device no larger than a smartphone to identifying autism through a strand of hair, emerging technologies are truly amazing. Despite their wow-factor, will payers jump to reimburse these tests? And can health systems integrate these innovations without creating new economic barriers? The direct-to-consumer diagnostic market is gaining steam, hopefully pushing the traditional health system into a diagnostic-driven future.